Sentences with phrase «nuclear plant systems»

As the U.S. nuclear industry and its regulator, the U.S. Nuclear Regulatory Commission (USNRC), implement these actions, the report recommends particular attention to improving the availability, reliability, redundancy, and diversity of specific nuclear plant systems:

Nuclear plant operators and regulators in the U.S. and other countries are taking useful actions to upgrade nuclear plant systems, operating procedures, and operator training in response to the Fukushima Daiichi accident.

Not exact matches

(Among other things, it's used for real - time control systems in nuclear power plants.)

More likely, there are still nuclear plants running, and there may even be some natural gas plants lingering in the system — not running at full capacity, but they have the ability to power up quickly when there's not a lot of sun or wind.

High - reliability - organization (HRO) practices help prevent catastrophic failures in complex systems like nuclear power plants through early detection.

In 2011, following the crisis at the Fukushima Daiichi nuclear power plant, Japan shut down and reviewed its nuclear energy system.

The Trump administration accused Russia of engineering a series of cyberattacks that targeted American and European nuclear power plants and water and electric systems, and could have sabotaged or shut power plants off at will.

In August 2008, however, the DEC affirmed that the Indian Point nuclear power plant's cooling water intake system causes adverse environmental impacts on Hudson River fish.

And upstate Republican lawmakers are cheering the adoption as well, given the standards include a system that would subsidize nuclear energy as Entergy Corp. seeks to sale central New York's FitzPatrick Nuclear Powernuclear energy as Entergy Corp. seeks to sale central New York's FitzPatrick Nuclear PowerNuclear Power Plant.

Cuomo's plan to bail out upstate nuclear plants could end up raising electricity expenditures for health systems around the state by at least $ 13.4 million, according to a report by a consumer utility advocacy group.

The New York Independent System Operator released a report analyzing the retirement of the Indian Point nuclear plant, concluding that system reliability criteria can be met with one or more types of solutions including generation, transmission, energy efficiency, and demand response meaSystem Operator released a report analyzing the retirement of the Indian Point nuclear plant, concluding that system reliability criteria can be met with one or more types of solutions including generation, transmission, energy efficiency, and demand response measystem reliability criteria can be met with one or more types of solutions including generation, transmission, energy efficiency, and demand response measures.

His campaign issued a statement saying, in part, that «the Governor has led the nation in combating climate change», including, closing down the «dangerous» Indian Point nuclear power plant and implementing the first multi-state cap and trade system to lower carbon pollution.

My campaign is calling for 100 % Clean Energy in New York by 2030, including a complete ban on fracking, a phase out of all nuclear plants, no new fossil fuel infrastructure, and the rapid development of a clean energy system based on distributed renewable energy production from solar, wind, and water resources and an interactive smart grid.

Each day, some two billion gallons of water are pumped from Long Island Sound into the Millstone Power Station in Waterford, Conn. — that state's only nuclear power plant — and used to help cool systems and support the station's two operating reactors.

They'll talk about the transition from the Senate, the death of a New York State Trooper, the state's correction system, the Indian Point nuclear power plant and much more.

Peculiarities of the electricity system in New York State, including its unusual independent status, would make it difficult and expensive to replace electricity from the Indian Point nuclear power plant if Gov. Andrew M. Cuomo succeeds in shutting it down, experts on the grid warn.

And there is some somewhat alarming language that talks about, and I'll just quote «the IAEA tells us the earthquake triggered a power failure at the Fukushima Daiichi unit 2 nuclear power plant, and then when a backup generator also failed, the cooling system was unable to supply water to cool the reactor.

The program was designed to attack and sabotage control systems used in manufacturing facilities, power grids, pipelines, and nuclear plants.

The IAEA should consider a system of compulsory peer reviews of nuclear plant operators and national nuclear regulatory organizations, they add.

«Our inspectors found all the reactors would be kept safe even in the event their regular safety systems were affected by these events, although a few plants have to do a better job maintaining the necessary resources and procedures,» said Eric Leeds, director of the NRC's Office of Nuclear Reactor Regulation.

The 1989 disturbance, which was felt by power systems deep into the United States and damaged a transformer at a nuclear plant, is far from the maximum.

The Japan Atomic Industrial Forum, an industry body, estimates that core cooling systems are not functioning at all three Fukushima Daiichi operating reactors and two of the four reactors at the nearby Fukushima Daini nuclear power plant are relying on backup cooling systems.

Nuclear generating plants are generally the largest on our system because of the necessary economies of scale.

But what is clear is that several nuclear power plants in the U.S. have the same safety systems that failed in Japan.

Nuclear power opponents like Jim Warren, executive director of NC Warn in North Carolina, have challenged the NRC's approach to regulating fire risks to wiring that connects vital control systems in old plants.

Networks are used in electrical power grids, nuclear power plants, financial systems, transportation systems, health...

Networks are used in electrical power grids, nuclear power plants, financial systems, transportation systems, health care systems, identification systems (including the new biometric chips in U.S. passports), and U.S. federal agencies» operations and assets.

Initially, the monitoring system will be tested at two nuclear power plants in Ukraine and Belarus.

If it is implemented in major set ups such as nuclear plants, the system is capable of transferring a tremendous amount of heat which can be rechanneled as an additional source of energy.

The point was to prove that a nuclear power facility could be built as cheaply as a coal - fired power plant, and the key to that was a smaller safety system.

«Hydropower plants and thermoelectric power plants — which are nuclear, fossil -, and biomass - fueled plants converting heat to electricity — both rely on freshwater from rivers and streams,» explains Michelle Van Vliet, a researcher at the International Institute for Applied Systems Analysis (IIASA) in Austria and Wageningen University in the Netherlands, who led the study.

Over the next few months, suppliers of radiation monitoring systems will be asked to tender for a «gamma curtain'to surround these nuclear power plants.

It is seriously vulnerable there, as the Fukushima accident demonstrated, and so the academy panel recommends that the U.S. Nuclear Regulatory Commission (NRC) and nuclear plant operators beef up systems for monitoring the pools and topping up water levels in case a facility is dNuclear Regulatory Commission (NRC) and nuclear plant operators beef up systems for monitoring the pools and topping up water levels in case a facility is dnuclear plant operators beef up systems for monitoring the pools and topping up water levels in case a facility is damaged.

For an understanding of how nuclear plant safety is assessed and will likely be evaluated moving forward, Scientific American spoke with Najmedin Meshkati, a professor of civil, environmental, industrial and systems engineering at the University of Southern California's Viterbi School of Engineering in Los Angeles.

Recognition of Workers» Compensation Claims of Nuclear Power Plant Workers in Japan and the Beginning of an International Comparative SurveyThe number of workers registered under the Exposure Dose Registration and Management System up to...

Today, Ultra systems are installed at over 500 nuclear plants and facilities around the world.

With RCI's vast knowledge of I&C systems for nuclear power plants, they also provide expertise in the areas of neutron monitoring, in - core instrumentation, and process sensors for monitoring the safety critical aspects of the NuScale Power Module (NPM).

At the same time, OSU was gaining international recognition for its work in the development of passive safety systems that use natural circulation to provide cooling for nuclear plants.

We then show that an adapted HK functions in plants by linking it to a transcriptional response through signal - dependent nuclear translocation of a bacterial response regulator [12], to produce a synthetic signal transduction system.

To enable such a system in plants, the re-designed receptors need to be targeted extracellularly and we need to address eukaryotic processes that are not fully understood, such as transmembrane signaling, signal - dependent nuclear translocation, and other signaling complexities.

Incorporating an interim fuel storage system (HI - STORM UMAX) into the base SMR - 160 plant offering is a first - of - a-kind feature for any nuclear power plant, and will eliminate the need for major subsequent plant modifications and upgrades later in plant life, typically in excess of $ 100M.

Q24: What is Holtec's experience in designing gravity - driven systems for nuclear plants?

Response: Unlike currently operating nuclear reactors, SMR - 160 has been designed to store the used fuel produced over the entire operating lifetime of the plant in subterranean cavities (formally known as Holtec's HI - STORM UMAX system licensed by the USNRC), occupying a small parcel of land in the plant's backyard.

Response: The Fukushima accident happened when flooding of power plant safety systems caused by the tsunami prevented operation of pumps needed to cool the nuclear fuel within the reactor and the fuel storage pools, causing that irradiated fuel to overheat.

All systems that are important - to - safety — to ensure that the plant's nuclear fuel is always cooled — are run purely by gravity.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transNuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transnuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transNuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transNuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

The first commercial 12 - module power plant, which will be owned by Utah Associated Municipal Power Systems and run by an experienced nuclear operator, Energy Northwest, is planned for construction on land owned by the US Department of Energy at the Idaho National Laboratory.

The technology is also used in cardiac monitoring systems, nuclear power plants and weapons systems.

This is why the hydrogen economy requires hundreds of Nuclear power plants or solar sytems or geothermal systems to produce the hydrogen.

Shouldn't the license to build and operate a nuclear power plant demand that safety systems be designed around a WORST CASE SCENARIO?